RESPIREE SECURES SINGAPORE HSA CLEARANCE FOR PEDIATRIC EXPANSION OF CARDIO-RESPIRATORY WEARABLE AND FOR ITS NEW EHR STREAMLINED PLATFORM

WHY IT MATTERS WHY IT MATTERS "This important regulatory extension enablesSingapore'shealthcare systems, as well as other international healthcare systems, to accurately capture and utilize cardio-respiratory data in a broader pediatric population, beyond just adults. Furthermore, Respiree's software platform now streamlines workflow integration, facilitating seamless transitions of care not only within hospitals but also from hospitals to homes through our new pathway management...
Comunicato Precedente

next
Comunicato Successivo

next

WHY IT MATTERS

"This important regulatory extension enables Singapore's healthcare systems, as well as other international healthcare systems, to accurately capture and utilize cardio-respiratory data in a broader pediatric population, beyond just adults. Furthermore, Respiree's software platform now streamlines workflow integration, facilitating seamless transitions of care not only within hospitals but also from hospitals to homes through our new pathway management services. This enhancement allows for more efficient and streamlined care," stated Dr. Gurpreet Singh, CEO and Founder of Respiree.

With the expanded HSA clearance, Respiree sets its sights on securing additional regulatory approvals in other APAC regions, including the USA, within the next few months. Furthermore, Respiree plans to pursue clearances for its AI-powered Software-as-a-Medical-Device (SaMD), which will seamlessly integrate into its existing enterprise solution, bolstering its capabilities and impact on patients' lives.

RESPIREE SECURES SINGAPORE HSA CLEARANCE FOR PEDIATRIC EXPANSION OF CARDIO-RESPIRATORY WEARABLE AND FOR ITS NEW EHR STREAMLINED PLATFORM

About Respiree

Respiree™ is an AI/ML health tech company building clinically-validated AI for managing disease progression. Respiree™ is CE marked and has received regulatory clearances from the Therapeutic Goods Administration and the United States Food and Drug Administration (FDA).

Photo - https://mma.prnewswire.com/media/2628190/Illustrative_Image_Respiree_s_RS001_Cardio_respiratory_Wearable_With_Connected_IOT_Platform.jpg
Logo - https://mma.prnewswire.com/media/2386657/Respiree_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/respiree-secures-singapore-hsa-clearance-for-pediatric-expansion-of-cardio-respiratory-wearable-and-for-its-new-ehr-streamlined-platform-302385915.html

Ufficio Stampa

 PR Newswire (Leggi tutti i comunicati)
209 - 215 Blackfriars Road
LONDON United Kingdom

Allegati
Slide ShowSlide Show
Non disponibili
;